Lorcaserin therapy for severe epilepsy of childhood onset: A case series

Neurology. 2018 Oct 30;91(18):837-839. doi: 10.1212/WNL.0000000000006432. Epub 2018 Sep 26.

Authors

Patricia Tolete¹, Kelly Knupp², Michael Karlovich², Elaine DeCarlo², Judith Bluvstein², Erin Conway², Daniel Friedman², Patricia Dugan², Orrin Devinsky²

Affiliations

¹ From NYU Langone Health (P.T., M.K., J.B., E.C., D.F., P.D., O.D.), New York; Children's Hospital Colorado (K.K.), Aurora; and RWJ Barnabas Health (E.D.), West Orange, NJ. patricia.tolete@nyumc.org.
² From NYU Langone Health (P.T., M.K., J.B., E.C., D.F., P.D., O.D.), New York; Children's Hospital Colorado (K.K.), Aurora; and RWJ Barnabas Health (E.D.), West Orange, NJ.

No abstract available

MeSH terms

Adolescent
Adult
Anticonvulsants / therapeutic use*
Benzazepines / therapeutic use*
Child
Child, Preschool
Drug Resistant Epilepsy / drug therapy*
Female
Humans
Male
Retrospective Studies
Treatment Outcome
Young Adult

Substances

Anticonvulsants
Benzazepines
lorcaserin